Note 6 - Shareholders' Equity

12 Months Ended

Feb. 26, 2017

Stockholders' Equity Note Disclosure [Text Block]

6.	SHAREHOLDERS’ EQUITY

Treasury Stock

– On

January

2015,

the Company announced that its Board of Directors has authorized the Company’s purchase, on the open market and in privately negotiated transactions, of up to

1,250,000

shares of its common stock, representing approximately

of the Company’s

20,945,634

total outstanding shares as of the close of business on

January

2015.

This authorization superseded all prior Board of Directors’ authorizations to purchase shares of the Company’s common stock.

March

10,

2016,

the Company announced that its Board of Directors authorized the Company’s purchase, on the open market and in privately negotiated transactions, of up to

1,000,000

additional shares of its common stock, in addition to the unused prior authorization to purchase shares of the Company’s common stock announced on

January

2015.

As a result, the Company is authorized to purchase up to a total of

1,531,412

shares of its common stock, representing approximately

7.6%

of the Company’s

20,234,671

total outstanding shares as of the close of business on

May

2017.

During the

2016

fiscal year, the Company purchased

599,832

shares pursuant to the above authorizations at an aggregate purchase price of

$12,187,

leaving

1,531,412

shares that

may

be purchased pursuant to the

January

2015

and

March

10,

2016

authorizations.

Reserved Common Shares

– At

February

26,

2017,

1,466,030

shares of common stock were reserved for issuance upon exercise of stock options.

Accumulated Other Comprehensive Earnings

– Accumulated balances related to each component of other comprehensive earnings were as follows:

	February 26, 2017			February 28, 2016

Currency translation adjustment	$	1,360		$	1,330
Unrealized gains (losses) on investments, net of taxes of $(180) and $76, respectively		(334	)		141
Accumulated balance	$	1,026		$	1,471